Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:01 AM ET 8-K
Financial Results Reservoir Media, Inc. RSVR

Reservoir Media Financial Results

Reservoir Media reported second quarter fiscal 2027 revenue of $49.9 million, a 10% increase year-over-year driven by strong performance in Recorded Music and Music Publishing. Net income rose to $4.6 million, or $0.07 per share, and the company raised its full-year outlook for revenue and Adjusted EBITDA.

Term
Q2 2027

“Our second quarter results marked the end of a strong first half of fiscal 2027, with growth across both our Publishing and Recorded Music segments reflecting the continued successful execution of our long-term strategy.”

Golnar Khosrowshahi, Founder and Chief Executive Officer

“We continue to thoughtfully expand and diversify our portfolio, while deepening our established reputation as a trusted steward for exceptional music talents and catalogs. We remain confident in our ability to build on this momentum for the remainder of fiscal year 2027.”

Golnar Khosrowshahi, Founder and Chief Executive Officer
8:01 AM ET 10-Q
Financial Results Burford Capital Ltd BUR

Burford Capital Q3 2026 Results: Turns Profitable, Net Income $23.4M

Burford Capital Ltd's Form 10-Q for the period ended September 30, 2026, details the company's performance in the legal finance market, emphasizing realized gains from portfolio resolutions and the valuation of capital provision assets. The report provides updates on liquidity management and the scaling of its investment portfolio amidst evolving litigation trends.

Key figure
Net income $23.4M
8:01 AM ET 8-K
Financial Results Trinity Capital Inc. TRIN

Trinity Capital Financial Results

Trinity Capital reported record third-quarter 2026 financial results, with net investment income (NII) growing 34.9% year-over-year to $49.9 million. The company funded $614.1 million in gross investments during the quarter, driving total platform assets under management to $3.4 billion. Net Asset Value (NAV) per share increased to $13.61, supported by a 15.5% return on average equity.

Term
Q3 2026

“The third quarter was another step in building a platform designed to perform across market environments. We funded $614 million, grew platform AUM to $3.4 billion, and continued to expand our managed funds offering, enhancing returns for TRIN beyond the income generated by our BDC portfolio. We like the foundation we’ve built, and we’re excited about what’s next for TRIN and our shareholders.”

Kyle Brown, Trinity Capital CEO
8:01 AM ET 10-Q
Financial Results Neuronetics, Inc. STIM ▶ Call

Neuronetics Q3 2026 Results: Net Loss of $1.69M, Loss Narrows

Neuronetics, Inc. reported total revenues of $41.96 million for the quarter ended September 30, 2026, a 12.5% increase over the prior year, driven primarily by growth in the Greenbrook segment. The company achieved a quarterly income from operations of $0.54 million compared to a loss of $7.32 million in the prior year, though it maintained a net loss of $1.56 million for the period.

Key figure
Net loss $1.69M
8:01 AM ET 8-K
Financial Results American Financial Group Inc AFG

American Financial Group Financial Results

American Financial Group reported record third quarter core net operating earnings of $3.97 per share, driven by higher net investment income and strong P&C operating performance. Alongside the results, the Board of Directors declared a special one-time cash dividend of $3.50 per share payable on November 25, 2026. The company also updated its full-year 2026 core net operating earnings guidance to a range of $12.30 to $12.80 per share.

Term
Q3 2026
8:01 AM ET 8-K
Financial Results Harmony Biosciences Holdings, Inc. HRMY

Harmony Biosciences Holdings Financial Results

Harmony Biosciences reported Q3 2026 financial results with WAKIX net revenue of $269 million, driven by 400 net patient additions. The company reaffirmed its full-year 2026 revenue guidance of $1.0 billion to $1.04 billion and announced that Peter Anastasiou will succeed Jeffrey Dayno as CEO effective January 1, 2027.

“As I prepare to transition the President and CEO role to Peter on January 1, I believe Harmony is operating from a position of strength, with a durable and growing WAKIX franchise, the financial flexibility to invest in innovation, conviction to pursue strategic business development opportunities, and a pipeline led by BP-205 that has the potential to generate significant long-term value.”

Jeffrey Dayno, MD, President and Chief Executive Officer

“I am proud of the talented team and passionate organization we have built, which position Harmony for continued success in delivering innovative treatments to patients and sustained value for our shareholders.”

Jeffrey Dayno, MD, President and Chief Executive Officer
8:01 AM ET 8-K
Leadership Change Childrens Place, Inc. PLCEQ

Childrens Place Leadership Change

The Children’s Place announced a major leadership shakeup including the resignations of Muhammad Asif Seemab as President and Interim CEO, Muhammad Umair as Chief Strategy Officer, and Turki Saleh A. AlRajhi as Executive Chairman. CFO John Szczepanski has assumed the role of acting President and principal executive officer, while AlRajhi will remain Chairman of the Board. Additionally, director Kim Roy resigned from the board effective October 30, 2026.

8:01 AM ET 8-K
Financial Results Burford Capital Ltd BUR

Burford Capital Financial Results

Burford Capital reported its financial results for the third quarter and first nine months of 2026, highlighting total revenues of $135 million. The company achieved $100 million in de-leveraging and ended the period with over $500 million in cash on hand.

Term
Q3 2026

“Burford had its strongest quarter this year, with robust portfolio activity and good cash generation. Total revenues of $135 million would have been well over $200 million if not for the non-cash increase in market discount rates. We also achieved $100 million of de-leveraging and retired our nearest-term debt maturity. We closed the quarter with more than a half-billion dollars of cash on hand.”

Christopher Bogart, Burford Capital’s Chief Executive Officer
8:01 AM ET 8-K
Financial Results Atlanta Braves Holdings, Inc. BATRA

Atlanta Braves Holdings Financial Results

Atlanta Braves Holdings reported third quarter 2026 financial results, with total revenue increasing 4% to $325 million driven by higher baseball event revenue and mixed-use development rental income. Operating income declined significantly to $9 million from $39 million in the prior year period, primarily due to increased player salaries. The company highlighted a 14% increase in average regular season home game attendance and the successful first season of its direct-to-consumer platform, BravesVision.

Term
3 months
8:01 AM ET 8-K
Leadership Change Siebert Financial Corp SIEB

Siebert Financial Leadership Change

Siebert Financial Corp. appointed Richard S. Gebbia and David J. Gebbia as Co-Chief Executive Officers, effective November 4, 2026. They succeed John J. Gebbia, who will step down from the CEO role but remain as Chairman of the Board.

7:55 AM ET 8-K
Financial Results Neuronetics, Inc. STIM

Neuronetics Financial Results

Neuronetics reported Q3 2026 total revenue of $42.0 million, a 12.5% increase year-over-year, driven primarily by 20.1% growth in its Greenbrook clinic segment. The company achieved a significant turnaround in profitability, reporting positive Adjusted EBITDA of $1.9 million and income from operations of $0.5 million compared to losses in the prior year period.

Term
Q3 2026

“This quarter showed our strategy taking hold across our business. We delivered a record third quarter within Greenbrook as well as NeuroStar system sales. This reflects both our revenue cycle management advances as well as the positive reception of our expanded NeuroStar go-to-market options. We also continued to demonstrate our prioritization on profitability and cashflow generation.”

Dan Reuvers, President and Chief Executive Officer of Neuronetics
7:47 AM ET 8-K
Financial Results Peabody Energy Corp BTU

Peabody Energy Financial Results

Peabody Energy reported Q3 2026 financial results with a net loss of $32.8 million and Adjusted EBITDA of $97.5 million, showing improved momentum across its seaborne operations. The company also declared a quarterly dividend of $0.075 per share and completed the repurchase of $38.9 million of its 2028 convertible notes.

Term
Q3 2026

“The third quarter demonstrated improving momentum across the portfolio with all segments reporting positive Adjusted EBITDA while our seaborne operations benefited from higher pricing. During the quarter, we worked through higher-cost faulted conditions at Centurion, which slowed advance rates, although the mine still reached its third quarter sales targets.”

Jim Grech, President and Chief Executive Officer
7:47 AM ET 8-K
M&A Deal Eagle Nuclear Energy Corp. NUCL

Eagle Nuclear Energy M&A Deal with Noble Plains Uranium Corp.

Eagle Nuclear Energy Corp. has signed a binding letter of intent to acquire 100% of Noble Plains Uranium Corp. in an all-stock transaction. The deal values Noble Plains at CAD $0.125 per share, a 92% premium, and will expand Eagle's domestic uranium portfolio into Wyoming's Powder River and Shirley basins.

Counterparty
Noble Plains Uranium Corp.
7:47 AM ET 8-K
Financial Results XPEL, Inc. XPEL

XPEL Financial Results

XPEL, Inc. reported third quarter 2026 revenue of $137.8 million, a 9.9% increase year-over-year, driven by gross margin expansion to 44.6%. Net income grew 26.3% to $16.3 million, while the company highlighted ongoing progress with its manufacturing investments in San Antonio and China.

Term
Q3 2026

“We delivered a solid third quarter in a challenging environment, growing revenue nearly 10% and expanding gross margin for the third consecutive quarter. Our manufacturing investments in San Antonio and China remain on track, and we are confident they will drive meaningful margin expansion in the years ahead.”

Ryan Pape, President and Chief Executive Officer
7:41 AM ET 10-Q
Financial Results NewAmsterdam Pharma Co N.V. NAMS

NewAmsterdam Pharma Co Q3 2026 Results: Net Loss of $17.4M, Loss Narrows

NewAmsterdam Pharma reported a net loss of $130.0 million for the nine months ended September 30, 2026, compared to $128.9 million in the prior year period. Revenue increased significantly to $25.9 million, primarily driven by $19.2 million in the third quarter, while the company maintained a strong liquidity position with $423.1 million in cash and cash equivalents.

Key figure
Net loss $17.4M
7:41 AM ET 8-K
M&A Deal Spectrum Brands Holdings, Inc. SPB

Spectrum Brands Holdings Signs $1.6B M&A Deal with Helen of Troy Limited

Spectrum Brands' joint venture, Empower Brands, has submitted a non-binding proposal to acquire all outstanding shares of Helen of Troy Limited for $37.00 per share in cash. The deal implies an enterprise value of approximately $1.6 billion and represents a 31% premium over the target's 30-day volume-weighted average share price. Empower Brands, which is jointly owned by Spectrum Brands and Oaktree Capital Management, already holds a 4.5% stake in Helen of Troy.

Value
$1.6B
Counterparty
Helen of Troy Limited
7:40 AM ET 8-K
Financial Results Madison Square Garden Entertainment Corp. MSGE

Madison Square Garden Entertainment Financial Results

Madison Square Garden Entertainment Corp. reported fiscal first quarter 2027 revenues of $217.1 million, a 37% year-over-year increase driven by a record number of concerts at The Garden. The company achieved operating income of $9.7 million, a significant improvement from a loss in the prior year, and repurchased $25 million of its Class A common stock during the quarter.

Term
Q1 2027

“Our business is off to a strong start in fiscal 2027. We expect our live entertainment offerings to continue benefiting from healthy demand and we remain well positioned to drive robust growth in both revenue and adjusted operating income this fiscal year.”

James L. Dolan, Executive Chairman and CEO
7:39 AM ET 8-K
Financial Results Royalty Pharma plc RPRX

Royalty Pharma Financial Results

Royalty Pharma reported 9% growth in Portfolio Receipts to $890 million for the third quarter of 2026, driven by strong performance from Tremfya, Voranigo, and Evrysdi. The company raised its full-year 2026 Portfolio Receipts guidance to a range of $3.50 billion to $3.55 billion. Management highlighted $1.9 billion in announced transactions year-to-date, including new royalties on Zoryve and Mimrylo.

Term
Q3 2026

“Royalty Pharma delivered excellent third quarter 2026 results and we again raised our financial guidance. We delivered 9% growth in Royalty Receipts for the quarter and double-digit growth year-to-date. We continued to strengthen our portfolio by adding royalties on three innovative therapies in the third quarter. We have also seen tremendous clinical and regulatory progress across our portfolio, including FDA approvals of Revolution Medicines’ Rasonque and Teva’s Weltruza and positive Phase 3 results for Amgen’s Imdelltra.”

Pablo Legorreta, Royalty Pharma’s Chief Executive Officer and Chairman of the Board
7:36 AM ET 10-Q
Financial Results NCR Atleos Corp NATL

NCR Atleos Q3 2026 Results: Net Income $97M, Up 273.1% YoY

NCR Atleos Corp reported its financial results for the period ending September 30, 2026, highlighting a pending merger transaction with The Brink’s Company. The filing details risks related to its separation from NCR Voyix and ongoing business transformation, while reporting 73,939,883 shares of common stock outstanding as of October 28, 2026.

Key figure
Net income $97M · +273.1% YoY
7:36 AM ET 8-K
Financial Results Fidelity National Information Services, Inc. FIS

Fidelity National Information Services Financial Results

Fidelity National Information Services (FIS) reported third quarter 2026 revenue of $3.5 billion, a 27% increase on a GAAP basis, driven by the acquisition of Total Issuing Solutions. The company updated its full-year 2026 outlook, projecting adjusted revenue growth of 28-29% and free cash flow between $2.15 billion and $2.25 billion.

“Client demand remains strong, and we are continuing to invest in what our clients care about most, security and innovation. These investments will build a more recurring, predictable revenue base for FIS. The long-term payoff is significantly deeper client relationships, a stronger competitive position, and a business built for durable growth.”

Stephanie Ferris, FIS CEO and President
7:35 AM ET 8-K
Financial Results NewAmsterdam Pharma Co N.V. NAMS

NewAmsterdam Pharma Co Financial Results

NewAmsterdam Pharma reported third quarter 2026 financial results and highlighted the European Commission's approval of Ubeslo and Evlarco for hypercholesterolaemia. The company ended the quarter with $643.1 million in cash and expects an interim analysis of its PREVAIL cardiovascular outcomes trial in Q4 2026.

“The third quarter was marked by significant progress across our regulatory and clinical priorities, including the first regulatory approval of obicetrapib worldwide and the initiation of the SPINOZA Phase 2b trial in preclinical Alzheimer’s disease. Looking ahead, we anticipate reaching the predefined event number for the planned PREVAIL interim analysis in the fourth quarter, with the outcome expected in the first quarter of 2027.”

Michael Davidson, M.D., Chief Executive Officer of NewAmsterdam Pharma
7:35 AM ET 8-K
Financial Results Medline Inc. MDLN

Medline Financial Results

Medline reported Q3 2026 net sales of $7.9 billion, a 10.4% increase year-over-year, driven by new customer signings and existing customer growth. The company raised its full-year organic sales guidance and announced a new $1 billion share repurchase program authorized by the Board of Directors.

Term
Q3 2026

“Medline delivered another strong quarter, with double-digit net sales growth, reflecting continued momentum across our business. Our commercial execution remains strong, including continued progress toward our annual total new customer signings goal.”

Jim Boyle, chief executive officer of Medline
7:35 AM ET 8-K
Financial Results Foster L B Co FSTR

Foster L B Financial Results

L.B. Foster reported strong Q3 2026 results with sales increasing 21.5% to $168.0 million and net income growing 56.5% to $6.8 million. The company generated $23.6 million in operating cash flow, reducing total debt to $28.7 million, its lowest level in a decade.

Term
Q3 2026

“We started the second half of the year with strong momentum, delivering meaningful growth in sales, profitability, and cash generation during the third quarter. Sales increased 21.5% over the prior year quarter, reflecting strong growth across both segments, while Adjusted EBITDA increased 15.1%.”

John Kasel, President and Chief Executive Officer

“Our third quarter operating cash flow of $23.6 million enabled us to reduce total debt by $19.3 million during the quarter and by $30.0 million compared to the prior year quarter, to the lowest level in over a decade.”

John Kasel, President and Chief Executive Officer
7:34 AM ET 8-K
Financial Results Scotts Miracle-Gro Co SMG

Scotts Miracle-Gro Financial Results

Scotts Miracle-Gro reported fiscal 2026 full-year net sales of $3.29 billion, a 1% increase driven by branded product growth and e-commerce expansion. Non-GAAP adjusted EPS of $4.48 exceeded guidance, and the company strengthened its balance sheet by reducing its net leverage to 3.89x.

Term
FY2026

“I’m pleased with our performance and financial discipline in fiscal 2026, as we delivered on all our imperatives and significantly strengthened our balance sheet.”

Nate Baxter, president and CEO

“We met or exceeded our fiscal 2026 commitments for net sales, gross margin, EPS, free cash flow and leverage ratio.”

Mark Scheiwer, chief financial officer and chief accounting officer
7:33 AM ET 8-K
Financial Results NCR Atleos Corp NATL

NCR Atleos Financial Results

NCR Atleos reported Q3 2026 revenue of $1.1 billion and net income of $97 million, representing a 273% year-over-year increase in net income. The company noted that its pending merger with The Brink’s Company is on track to close in early January 2027, with integration planning confirming the strategic rationale for the deal.

Term
Q3 2026

“Atleos delivered strong third quarter profit growth and a very good first nine months of 2026 despite revenue challenges from the war in the Middle East and some customers delaying buying decisions in anticipation of the combined companies new solutions.”

Tim Oliver, Atleos’ Chief Executive Officer

“As we close out the third quarter, our results continue to reflect disciplined execution against our internal plan. We have been able to deliver strong financial results with year-over-year Adjusted EBITDA and EPS growth of 10% and 24%, respectively.”

Andy Wamser, Chief Financial Officer
7:32 AM ET 10-Q
Financial Results Vishay Intertechnology Inc VSH

Vishay Intertechnology Q3 2026 Results: Turns Profitable, Net Income $59M

Vishay Intertechnology reported net revenues of $978.9 million for the fiscal quarter ended October 3, 2026, a significant increase from $790.6 million in the prior year. The company returned to profitability with net earnings of $59.0 million compared to a net loss of $7.9 million in the same period last year, supported by a follow-on public offering that raised $830.3 million.

Key figure
Net income $59M
7:31 AM ET 8-K
Financial Results Riot Platforms, Inc. RIOT

Riot Platforms Financial Results

Riot Platforms reported Q3 2026 financial results, highlighted by a massive 15-year, 910 MW powered land lease at its Corsicana campus with a leading Frontier AI Lab. The lease represents approximately $28 billion in total contract value and is expected to generate $1.8 billion in average annual net operating income.

“Today, we are excited to announce the largest lease in Riot’s history: a 15-year triple-net powered land lease with a leading Frontier AI Lab for the entirety of our Corsicana campus, representing 910 megawatts of critical IT capacity and approximately $28 billion of contracted revenue over the initial term.”

Jason Les, CEO of Riot

“The structure of this new lease matters as much as the scale. With total capital costs of approximately $6 million per IT megawatt, the Corsicana development will require about half the capital of a Tier 3 build while significantly limiting procurement, development, and ongoing operational risk to Riot.”

Jason Les, CEO of Riot
7:31 AM ET 10-Q
Financial Results Latham Group, Inc. SWIM

Latham Group Q3 2026 Results: Net Income $12.1M, Up 48.5% YoY

Latham Group, Inc. reported net sales of $182.2 million for the fiscal quarter ended September 26, 2026, an increase from $161.9 million in the prior year period. Net income for the quarter rose to $12.1 million compared to $8.1 million, despite a $5.0 million loss on the extinguishment and modification of debt.

Key figure
Net income $12.1M · +48.5% YoY
7:31 AM ET 8-K
Financial Results Westlake Corp WLK

Westlake Financial Results

Westlake Corporation reported third quarter 2026 net sales of $2.98 billion and net income of $6 million, or $0.05 per diluted share. Results were impacted by $58 million in identified items, primarily related to previously announced facility shutdowns in the Performance and Essential Materials (PEM) segment. Excluding these items, adjusted net income was $58 million, or $0.45 per share, with an EBITDA margin of 14%.

Term
Q3 2026
7:31 AM ET 10-Q
Financial Results Dine Brands Global, Inc. DIN

Dine Brands Global Q3 2026 Results: Net Income $4.6M, Down 37.0% YoY

For the nine months ended September 27, 2026, Dine Brands Global reported total revenues of $715.0 million, an increase from $661.7 million in the prior year, primarily driven by a significant rise in company-owned restaurant revenues. However, net income decreased to $16.3 million from $29.3 million year-over-year, impacted by higher company-owned restaurant expenses and increased interest costs.

Key figure
Net income $4.6M · -37.0% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.